Literature DB >> 22118175

Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi.

M Kumwenda1, S Tom, A K Chan, E Mwinjiwa, S Sodhi, M Joshua, M van Lettow.   

Abstract

SETTING: In Malawi, human immunodeficiency virus (HIV) prevalence among newly registered tuberculosis (TB) patients is 60-70%. In 2008, an integrated TBHIV clinic was established at a central hospital in Zomba. Despite the integration of TB-HIV activities and improved HIV service uptake, unacceptably high proportions of HIV-positive TB patients are still not receiving antiretroviral therapy (ART).
OBJECTIVE: To identify factors that motivate or discourage TB patients from accepting HIV services.
DESIGN: Retrospective analysis of patients registered for TB treatment (not yet on ART) between April 2008 and March 2009; qualitative interviews of 99 patients on TB treatment.
RESULTS: Of 1773 newly registered TB patients who were not already on ART at the time of TB registration, 86% accepted HIV testing and counselling. Among HIV-positive TB patients, 38% started ART during or after anti-tuberculosis treatment. Young adults aged 15- 24 years were least likely to initiate ART. Motivation for accepting ART during TB treatment included prospects of regaining good health and longer life, and counselling by health care providers. Barriers to ART uptake included not being offered ART, high CD4 count, drug stockouts and fear of drug toxicities/interactions.
CONCLUSION: Several factors that undermine uptake of ART have been highlighted; targeted measures urgently need to be addressed by TB-HIV programmes to overcome these barriers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22118175     DOI: 10.5588/ijtld.10.0741

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  15 in total

1.  Antiretroviral treatment among co-infected tuberculosis patients in integrated and non-integrated facilities.

Authors:  T D Ledibane; S C Motlhanke; A Rose; W H Kruger; N R T Ledibane; M M Claassens
Journal:  Public Health Action       Date:  2015-06-21

2.  Timing and uptake of ART during treatment for active tuberculosis in HIV co-infected adults in Malawi.

Authors:  M van Lettow; A K Chan; A S Ginsburg; H Tweya; D Gareta; J Njala; H Kanyerere; S Phiri; I Idana
Journal:  Public Health Action       Date:  2011-09-21

3.  Antiretroviral therapy uptake among adult tuberculosis patients newly diagnosed with HIV in Nyanza Province, Kenya.

Authors:  H Muttai; K F Laserson; I Akello; L Nyabiage; J Gondi; J Mutegi; J Williamson; A K Nakashima; M-L Ackers
Journal:  Public Health Action       Date:  2013-12-21

4.  Timing of antiretroviral therapy and effects on tuberculosis treatment outcomes in HIV-co-infected patients in Malawi.

Authors:  H S Kanyerere; J Mpunga; H Tweya; M Edginton; A D Harries; S G Hinderaker; F Chimbwandira; A Gonani; K Mbendera
Journal:  Public Health Action       Date:  2012-10-30

5.  Barriers and facilitators to chemotherapy initiation and adherence for patients with HIV-associated Kaposi's sarcoma in Kenya: a qualitative study.

Authors:  Devon E McMahon; Rhea Singh; Linda Chemtai; Aggrey Semeere; Helen Byakwaga; Merridy Grant; Miriam Laker-Oketta; Celestine Lagat; Sigrid Collier; Toby Maurer; Jeffrey Martin; Ingrid V Bassett; Lisa Butler; Samson Kiprono; Naftali Busakhala; Esther E Freeman
Journal:  Infect Agent Cancer       Date:  2022-07-06       Impact factor: 3.698

Review 6.  The centrality of laboratory services in the HIV treatment and prevention cascade: The need for effective linkages and referrals in resource-limited settings.

Authors:  George Alemnji; Peter Fonjungo; Barbara Van Der Pol; Trevor Peter; Rami Kantor; John Nkengasong
Journal:  AIDS Patient Care STDS       Date:  2014-04-17       Impact factor: 5.078

7.  Are routine tuberculosis programme data suitable to report on antiretroviral therapy use of HIV-infected tuberculosis patients?

Authors:  Miranda Brouwer; Paula Samo Gudo; Chalice Mage Simbe; Paula Perdigão; Frank van Leth
Journal:  BMC Res Notes       Date:  2013-01-18

8.  Monitoring the impact of decentralised chronic care services on patient travel time in rural Africa--methods and results in Northern Malawi.

Authors:  Rein M G J Houben; Thomas P Van Boeckel; Venance Mwinuka; Peter Mzumara; Keith Branson; Catherine Linard; Frank Chimbwandira; Neil French; Judith R Glynn; Amelia C Crampin
Journal:  Int J Health Geogr       Date:  2012-11-15       Impact factor: 3.918

9.  Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi.

Authors:  Monique van Lettow; Ann Åkesson; Alexandra L C Martiniuk; Andrew Ramsay; Adrienne K Chan; Suzanne T Anderson; Anthony D Harries; Elizabeth Corbett; Robert S Heyderman; Rony Zachariah; Richard A Bedell
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

10.  Delayed initiation of anti-retroviral therapy in TB/HIV co-infected patients, Sanyati District, Zimbabwe, 2011-2012.

Authors:  Brian Abel Maponga; Daniel Chirundu; Notion Tafara Gombe; Mufuta Tshimanga; Donewell Bangure; Lucia Takundwa
Journal:  Pan Afr Med J       Date:  2015-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.